Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 51Terminated 16Recruiting 14Withdrawn 8Active not recruiting 3Unknown 2

Sponsor Class

NIH 5OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Breast Neoplasms 1475Neoplasms 996Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 682Stomach Neoplasms 646Lung Neoplasms 583Prostatic Neoplasms 543Pancreatic Neoplasms 457Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 289Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 276Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 240Multiple Myeloma 232Brain Neoplasms 203Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 191Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 140

Interventions

Thalidomide 1Prednisone 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Leukemia, Large Granular Lymphocytic × Clear all
NCT05941156 2023-07-12

Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia

The Affiliated Hospital of Xuzhou Medical University

Phase 2 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Large Granular Lymphocytic, Lymphoma, Extranodal NK-T-Cell

NCT04453345 2020-07-01

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Institute of Hematology & Blood Diseases Hospital, China

Phase 2/3 Unknown
42 enrolled
Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡